DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Share Price

Certificat

DE000ME9Z603

Real-time Bid/Ask 11:02:38 03/07/2024 BST
6.6 EUR / 6.96 EUR -0.88% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month+1.63%
1 month+116.46%
Date Price Change
02/07/24 6.84 +4.11%
01/07/24 6.57 -2.38%
28/06/24 6.73 0.00%
27/06/24 6.73 -2.32%
26/06/24 6.89 -1.57%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 06:51 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellPUT
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME9Z60
ISINDE000ME9Z603
Date issued 08/03/2024
Strike 70 $
Maturity 20/09/2024 (80 Days)
Parity 1 : 1
Emission price 2.59
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 7.02
Lowest since issue 1.47
Spread 0.49
Spread %6.90%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.24 USD
Average target price
83.43 USD
Spread / Average Target
+45.76%
Consensus